Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $4.5450 (-6.29%) ($4.5450 - $4.5450) on Mon. Sep. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.27% (three month average) | RSI | 36 | Latest Price | $4.5450(-6.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -5.3% a day on average for past five trading days. | Weekly Trend | IOVA declines -8.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) PEJ(98%) SDY(60%) SIL(98%) TLT(52%) SPLV(34%) | Factors Impacting IOVA price | IOVA will decline at least -2.635% in a week (0% probabilities). ICLN(-9%) IDRV(24%) IFRA(50%) IWD(54%) KWEB(1%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.635% (StdDev 5.27%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-11.92(-362.27%) | Resistance Level | $5.61 | 5 Day Moving Average | $5.02(-9.46%) | 10 Day Moving Average | $5.21(-12.76%) | 20 Day Moving Average | $5.61(-18.98%) | To recent high | -47.9% | To recent low | 0% | Market Cap | $666m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |